Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

People with alopecia areata have a higher risk of stroke.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

Folliculotropic mycosis fungoides can look like alopecia areata.

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Postmenopausal women may experience frontal hairline and eyebrow loss due to cicatricial fibrosis.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

JAK inhibitors might help treat alopecia areata.

Alopecia areata can regrow hair in a pattern similar to androgenetic alopecia.

Individualized homeopathic treatment may help improve hair loss and well-being in people with alopecia areata.

Most patients with alopecia areata did not achieve lasting hair regrowth despite treatment.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

A 19-year-old female with alopecia universalis experienced total hair loss, and previous treatments were ineffective.

Improved diagnosis and affordable topical treatments are essential for managing alopecia areata in India.

The guideline provides recommendations for managing alopecia areata effectively.

Trichoscopy is crucial for diagnosing alopecia areata by identifying specific hair features.

Alopecia areata in children causes hair loss and needs a personalized treatment plan with medical and emotional support.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

People with alopecia areata have higher insulin resistance.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Hair loss due to syphilis can be identified using trichoscopy and is treatable with antibiotics.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.